Fibrispa Tablet contains Mebeverine 135mg, an antispasmodic agent used primarily to relieve symptoms associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. Mebeverine works by relaxing the smooth muscles of the gastrointestinal tract, thereby reducing spasms, cramps, and abdominal pain without affecting normal gut motility. This action helps alleviate discomfort such as bloating, cramping, and irregular bowel movements commonly experienced in IBS. Fibrispa is typically prescribed to manage symptoms like abdominal pain, cramps, and altered bowel habits, improving overall digestive comfort. It is generally well-tolerated, with minimal side effects, though some patients may experience mild reactions such as nausea, dizziness, or headache. The medication should be taken as directed by a healthcare professional, usually before meals, to maximize its effectiveness. It is important to inform your doctor about any other medications or underlying health conditions before starting Fibrispa to avoid potential interactions. Pregnant or breastfeeding women should consult their physician prior to use. Fibrispa offers targeted relief from gastrointestinal spasms, enhancing quality of life for individuals suffering from functional bowel disorders by addressing the root cause of their symptoms.